Complete Genomics, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 66   

Articles published

GNOM 3.14
price chart
Sage Labs to be bought by UK company
Horizon Discovery Group, of Cambridge, England, said it is buying Sage for up to $16 million cash and up to $32 million in new stock in a deal it expects to complete Thursday. Horizon supplies research tools and services to organizations engaged in ...
Horizon Discovery beefs up management and offering with �29m Sage Labs ...  Cabume - Cambridge technology news
Horizon takes world lead with $48m Sage Labs acquisition  Business Weekly
Related articles »  
September windfall takes Cambridge deals to $44bn in 18 months
The news raced into the headlines just 24 hours after Horizon Discovery took a world lead in gene editing and translational genomics technology by agreeing to acquire the influential Sage Labs Inc in St Louis for up to $48 million in a cash plus share ...
Small Denver Company Pharmatech driving a large revolution in how cancer ...
30, 2014 /PRNewswire/ -- According to their CEO, Rob Bohacs - "the world of cancer clinical trials is going through a complete transformation with highly targeted biomarker clinical trials and the work of the current clinical trial management process ...
Related articles »  
People in the News: Olivier Danos, Frank Witney, John Radak
Witney is president and CEO of Affymetrix and Radak is CFO of the biotech product development firm ArborGen Inc. ... 19, 2014, two speakers outline applications of Rubicon Genomics' PicoPLEX DNA-seq single cell library preparation kit. ... In so doing ...
Related articles »  
Horizon Discovery Group plc acquires Sage Labs Inc. for $48M (�29M)
Horizon Discovery Group plc, the international life science company supplying research tools and services to organizations engaged in genomics research and the development of personalized medicines, today announced it has agreed to acquire Sage Labs ...
Agios Pharmaceuticals to Present at the 2014 Leerink Partners Rare Disease ...
23, 2014 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq:AGIO), a leader in the fields of cancer metabolism and rare genetic disorders of metabolism, today announced the company will webcast its presentation at the 2014 Leerink Partners Rare ...
Related articles »  
Agilent Gets Baa2 Rating from Moodys with Stable Outlook
The spin-off of EM is expected to be complete around Nov 1, 2014 and it will operate as a separate, publicly traded entity called Keysight Technologies.
Edico Genome Makes First Sale of NGS Processor
September 4, 2014 | The year of the thousand-dollar genome just got a little more interesting as Edico Genome, which makes a data processor called the DRAGEN for next generation sequencing (NGS) data, made its first sale to Sequenom, Inc. According to ...
Related articles »  
Single Molecule, Real-Time (SMRT) DNA Sequencing Tracks Infectious Disease ...
17, 2014 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc., (Nasdaq:PACB) provider of the PacBio� RS II DNA Sequencing System, announced the publication of several recent papers highlighting the advantages of Single Molecule, Real-Time (SMRT ...
Related articles »  
Google, AbbVie Announce Research Partnership
Human Longevity Inc., co-founded by genetics pioneer Craig Venter, is building a huge database of human genetic data to tackle age-related diseases including cancer, diabetes and obesity, heart and liver diseases, and dementia.
Related articles »